Dexcom launches continuous glucose monitoring system ONE+ in Ireland

Dexcom, a real-time continuous glucose monitoring (CGM) device manufacturer for people with diabetes, has launched its latest CGM system, Dexcom ONE+ in Ireland. Dexcom ONE+ uses Dexcom’s best-in-class and most accurate sensor design.

Dexcom also incorporated feedback from both end users and healthcare professionals when building Dexcom ONE+, ensuring an easy-to-use, highly effective, CGM experience for people treating their Type 1 or Type 2 diabetes with insulin. Furthermore, multiple studies have shown that the use of Dexcom real-time CGM sensors can offer cost savings to health services treating people with Type 1 diabetes.

Alex Moussa, senior vice president and general manager for Dexcom EMEA & LATAM, said: “Through our ongoing innovation and product development we are bringing the best, and most accurate, version of our technology to even more people and continuing to show our commitment to significantly expanding access to CGM for people with all types of diabetes. We are also on a mission to empower a healthier society and reduce the burden of care for healthcare providers around the world. This commitment is supported by numerous studies demonstrating the cost-saving benefits of CGM use, providing concrete evidence of its positive impact on healthcare systems.”

Dexcom CGM use has been proven to be more effective at reducing HbA1c than traditional blood glucose monitors (fingerpricking). Due to these consistent and proven improvements in health outcomes the use of Dexcom CGM was projected to be highly cost-effective versus both SMBG and is-CGM. Therefore, critically for healthcare providers and systems, the use of Dexcom ONE+ has the potential to reduce the costs of treating patients managing Type 1 diabetes.

The latest Dexcom sensor to launch in Ireland, Dexcom ONE+ has been created for people living with all types of diabetes and was designed based on end-user and HCP input. The entire Dexcom CGM portfolio is now available for people living with all types of diabetes in Ireland, from the unmatched capabilities of Dexcom G6 and G7 to help manage the health of higher risk populations and power Hybrid Closed Loop systems (HCL) to the easy to use and flexible Dexcom ONE+; Dexcom CGM use is supported by the most high-quality clinical studies and data of any CGM brand.

Dr. Liesbeth van Huffel, OLV Hospital Aalst, Belgium, said: “In my conversations with Dexcom, I expressed the importance of CGM being easy to use for people with diabetes and their care teams. Dexcom ONE+ is now an all-in-one sensor, very easy to apply and use. This makes diabetes technology more accessible as it lowers the barrier to getting started.

“Another important element was adding notes at certain moments, such as meals, insulin administration or sports activities. Compared to fingerpricks, a CGM sensor provides a much clearer picture of how daily choices affect glucose levels. Dexcom sensors are known for their accuracy and reliability and now adding this note option to Dexcom ONE+ makes it even more transparent for the care team when coaching someone.”

For people managing diabetes using fingerpricks and regularly injecting insulin, their lives can feel overwhelmed by diabetes. Dexcom ONE+ was developed to take away some of this burden, it’s easy to get started with and is designed to be easy to live with, even for those with no experience of using a CGM system. Like all Dexcom CGM, Dexcom ONE+ gives a clear picture of what glucose levels are doing in real-time, without painful fingerpricks, therefore making it easier for people to achieve lasting results. Importantly, for loved ones, Dexcom ONE+ also allows a user to easily share their glucose numbers with up to ten people, offering everyone a little more peace of mind.

Features that set Dexcom ONE+ apart from other CGM systems include multiple possibilities for personalisation and flexibility. Dexcom CGM systems offer the most discretion, with three wear location options and are the only CGM systems to offer a ‘delay first high’ option, a customisable feature which allows a user to set a time before which their sensor will not alert them to a ‘high’ glucose reading, helping to avoid alert fatigue. Furthermore, designed to fit seamlessly into a user’s life, Dexcom ONE+ also has the highest waterproof rating when compared to other CGM brands, allowing users to confidently continue using their device while showering or exercising.